Harvard University said the sale of some of its investments in Israel was not politically motivated and it is not divesting from Israel.

Harvard spokesman John Longbrake told Foreign Policy that the university sold $39 million in stocks in five Israeli companies because Israeli stocks could no longer be considered part of the emerging markets portfolio, where they previously had been held.

“The university has not divested from Israel,” Longbrake said. “Israel was moved from the MSCI, our benchmark in emerging markets, to the EAFE index in May due to its successful growth. Our emerging markets holdings were rebalanced accordingly.”

Forwarding the News

Thoughtful, balanced reporting from the Forward and around the web, bringing you updated news and analysis each day.

Terms(Required)

I agree to the Forward's Terms of Service and Privacy Policy

Email(Required)

He said Harvard is still invested in Israel but declined to go into specifics.

According to Foreign Policy, several of the stocks that were sold – Teva Pharmaceutical Industries, NICE Systems, Check Point Software Technologies, Cellcom Israel and Partner Communications – were doing poorly.

Nevertheless, the Boycott, Divestment and Sanctions for Palestine movement claimed a victory, according to Foreign Policy. The BDS campaign targets Israeli consumer, academic, cultural and sports organizations.

The Anti-Defamation League said the BDS campaign also claimed that Hampshire College divested from Israel in February 2009 – a claim that was rejected by the college.

The Forward is free to read, but it isn’t free to produce

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

This is a great time to support independent Jewish journalism you rely on. Make a gift today!

—  Rachel Fishman Feddersen, Publisher and CEO

Support our mission to tell the Jewish story fully and fairly.

$90 $180

$360

Other amount